Last reviewed · How we verify
NCT04669626: Odour
The Ability of Octenilin® to Reduce Odour of Malodorous Wound
NA trial testing Use of Ocetnilin in Wound in 20 participants. Completed in 22 December 2021.
30 November 2021
Quick facts
| Lead sponsor | School of Health Sciences Geneva |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 July 2020 |
| Primary completion | 30 November 2021 |
| Estimated completion | 22 December 2021 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Use of Ocetnilin
- Use of NaCl 0.9%
Conditions studied
- Wound — all drugs for Wound →
- Wound Heal — all drugs for Wound Heal →
Sponsor
School of Health Sciences Geneva
Who can join
18 and older, any sex, with Wound or Wound Heal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Malodours are a common complication of chronic wounds. They are the result of the proliferation of aerobic and anaerobic micro-organisms on the wound surface, where they metabolize healthy tissue which leads to the production of sloughy and even necrotic tissue. Wound odour has a big impact on the quality of life of patients. Currently the standard of care for the management of malodourous wounds are systemic antibiotics, absorbent wound dressings with or without activated carbon and, topical antimicrobials. The application of topical antimicrobials such as antiseptics against wound odour is part of the standard care. One suggested antiseptic in a recent published standard is Octenilin®. There is ample anecdotal evidence about the efficacy of Octenilin® in reducing wound odour. Therefore, we propose here to document this ability by evaluating the odour of wounds washed with Octenilin® versus standard care (NaCl 0.9% solution).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04669626
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wound
Currently open trials in the same condition.
- NCT07398534 — PICO Negative Pressure for Uninfected Foot Ulcers and Wound Dehiscence (BALPIC) · NA · active not recruiting
- NCT06957964 — Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds: A Randomized Clinical Trial · NA · recruiting
- NCT06801626 — Novel Strategies for Reducing Burn Scar Itch · Phase 3 · recruiting
- NCT06321978 — Mepilex Border Flex Utilization Pilot Spain · recruiting
- NCT06138964 — Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars · Phase 2 · recruiting
Other School of Health Sciences Geneva trials
Trials by the same sponsor.
- NCT07444151 — Post-Stroke Fatigue Perception Study (ReFast) · recruiting
- NCT07439367 — Multifocal Theta-Burst Stimulation to Enhance Upper Limb Motor Recovery After Stroke (INSPIRE) · NA · recruiting
- NCT05715190 — Development and Feasibility of a Nurse-led Person-centered Education Program · NA · enrolling by invitation
- NCT05912270 — Orchestra in Class, a Novel Booster for Executive Functions and Brain Development in Young Primary School Children · NA · recruiting
- NCT04370106 — The Impact of Frequenting a Social Leg Program on Therapeutic Adherence and Venous Leg Ulcer Wound Healing Outcomes · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04669626 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by School of Health Sciences Geneva
- Last refreshed: 11 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04669626.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing